Free Standard AU & NZ Shipping For All Book Orders Over $80!
Register      Login
New South Wales Public Health Bulletin New South Wales Public Health Bulletin Society
Supporting public health practice in New South Wales
Shopping Cart: ( empty )
You are here: Home > Journals > NB > NB07039
RESEARCH ARTICLE
Contents Vol 18(6)

Bug Breakfast in the Bulletin: Human Papilloma Virus

Cate Wallace A , Edith Weisberg B and Kirsten McCaffery C
+ Author Affiliations
- Author Affiliations

A NSW Public Health Officer Training Program, NSW Department of Health

B Research Division, Family Planning NSW

C Screening and Test Evaluation Program, University of Sydney

NSW Public Health Bulletin 18(6) 97-98 https://doi.org/10.1071/NB07039
Published: 25 July 2007


References


[1] Frazer IH,  Cox JT,  Mayeaux EJ,  Franco EF,  Moscicki AB,  Palefsky JM,  Ferris DG,  Ferenczy AS,  Villa LL. Advances in prevention of cervical cancer and other human papillomavirus-related diseases. Pediatr Infect Dis J 2006; 25 S65–81.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[2] O’Brien ED,  Bailie RS,  Jelfs PL. Cervical cancer mortality in Australia: contrasting risk by Aboriginality, age and rurality. Int J Epidemiol 2000; 29 813–6.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[3] Lowy DR,  Frazer IH. Chapter 16; Prophylactic human papillomavirus vaccines J Natl Cancer Inst Monogr 2003; 2003 111–6.


[4] Harper DM,  Franco EL,  Wheeler CM,  Moscicki A,  Romanowski B,  Roteli-Martins C,  Jenkins D,  Schuind A,  Costa Clemens S,  Dubin G. HPV vaccine study group sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial Lancet 2006; 367 1247–55.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[5] Ault KA. Vaccines for the prevention of human papillomavirus and associated gynaecological diseases: a review Obstet Gynnecol Surv 2006; 61 S26–31.
| Crossref | GoogleScholarGoogle Scholar |

[6] McCaffery K,  Waller J,  Forrest S,  Cadman L,  Szarewski A,  Wardle J. Testing positive for Human Papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG 2004; 111 1437–43.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[7] Havnegjerde T, Thoresen S. Knowledge of human papillomavirus among general practitioners in Norway. In: 21st International HPV Conference; Mexico City, Mexico; 2004.

[8] Marshall H,  Roberton D,  Ryan P,  Baghurst P. A cross sectional survey to assess attitudes to the introduction of Human Papillomavirus Vaccine. Aust NZ J Publ Heal 2007; 31 235–42.
| Crossref | GoogleScholarGoogle Scholar |

[9] Kahn JA,  Zimet GD,  Bernstein DI,  Riedesel J,  Lan D,  Huang B,  Rosenthal S. Pediatricians’ intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health 2005; 37(6): 502–10.
| Crossref | GoogleScholarGoogle Scholar | PubMed |